Minimal Residual Disease Gains Max US FDA AdComm Support For Myeloma Trials

ODAC meeting
ODAC members gathered in person for the 12 April meeting, but the public, press and open public hearing speakers participated virtually. • Source: screenshot
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA Performance Tracker

More from Regulatory Trackers